Identification of unique molecular heterogeneity of human CD79, the signaling component of the human B cell antigen receptor (BCR), and synergistic potentiation of the CD79-targeted therapy of B cell tumors by co-targeting of CD79a and CD79b
| Autor: | Seon, Ben K., Okazaki, Morihiro, Duzen, Jill, Matsuno, Fumihiko, Goey, Andrew K.L., Maguire, Orla |
|---|---|
| Zdroj: | In Leukemia Research January 2024 136 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect